LEATHERHEAD, England, July 3, 2025 /PRNewswire/ — MatOrtho® is proud to announce that the ReCerf® Hip Resurfacing Arthroplasty (HRA) has received its CE mark, confirming compliance with European safety and performance standards. This important milestone expands access to hip resurfacing, enabling wider availability across the UK, Europe and internationally where CE marking supports market access.

In a recent conversation with MedTech Spectrum, Trent Reutiman, CEO of ANACONDA Biomed, shared insights into the company’s CE Mark approval for the ANA5 Funnel Catheter—a next-generation device designed to improve clot capture and procedural outcomes in acute ischemic stroke treatment.

The number of colorectal cancer cases in people under 50 is rising worldwide, especially in high-income countries. Possible causes include Western diets, obesity, lack of exercise, and the use of antibiotics, especially in early life and adolescence.

A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and Luigi Naldini, has unveiled a powerful strategy to rejuvenate the effectiveness of chimeric antigen receptor (CAR) T cell therapy against glioblastoma, one of the most lethal and treatment-resistant brain tumors.